Skip to main content

Table 3 Morphologic classification of HCM

From: Left atrial volume predicts adverse cardiac and cerebrovascular events in patients with hypertrophic cardiomyopathy

  Total Group A Group B p-value
APH 21 (21%) 6 (25%) 15 (19%) 0.31
Type 1 7 (7%) 1 (4%) 6 (8%) 0.23
Type 2 4 (4%) 1 (4%) 3 (4%) 1.00
Type 3 61 (60%) 14 (59%) 47 (60%) 0.89
Type 4 9 (9%) 2 (8%) 7 (9%) 0.80
  1. APH, apical hypertrophy
  2. Type 1, basal septal hypertrophy
  3. Type 2, diffuse hypertrophy of the ventricular septum
  4. Type 3, diffuse hypertrophy of the ventricular septum and antero-lateral free wall
  5. Type 4, hypertrophy of the lateral wall